MedPath

Efficacy study of the carbon ion radiotherapy in 16 fractions for castration refractory prostate cancer

Not Applicable
Conditions
castration refractory prostate cancer
Registration Number
JPRN-UMIN000016763
Lead Sponsor
Working group of heavy ion therapy for genitourinary tumor, Gunma university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Past radiotherapy to the pelvic region 2) Past physical treatment of the prostate (TUR-P, HIFU, etc.) 3) Past chemotherapy within 4 weeks 4) Life expectancy is less than 6 months 5) Multiple malignancies within 5 years 6) Severe comorbidity 7) Judged inappropriate for this study by physicians

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
5-yr biochemical relapse free survival
Secondary Outcome Measures
NameTimeMethod
1) 5-yr overall survival 2) 5-yr cause specific survival 3) 5-yr local control 4) acute toxicity 5) late toxicity 6) QO
© Copyright 2025. All Rights Reserved by MedPath